Go Viral’s mission is to develop oncolytic virotherapy that improves survival and quality of life for cancer patients. We are currently focused on treatment for Glioblastoma Multiforme (GBM).
Go Viral is committed to developing viable treatment options for GBM. Our goal is a curative outcome with a focus on quality of life. Go Viral’s team is working to bring such outcomes to clinical use for patients..
Benjamin Gesundheit, MD PhD
Founder, CEO of Go Viral Ltd.
Innovation
Teamwork
Integrity
Excellence